Press release
Vascular Stent Market 2021 Research by Type, Product, Material, End User, Growth Rate, CAGR and Top Companies Analysis
Vascular Stent Market business report is a trustworthy source of market information for the business which assists with better decision making and outline better business strategies. Data and information included in this report aids businesses take superior decisions and improve return on investment (ROI). CAGR values mentioned in the report give evaluations about the rise or fall of the product demand in the forecasted time period. Under the competitive analysis section of the Vascular Stent Market research report, major key players existing in the market are revealed along with different details such as company profiles, their market share analysis, and their diverse strategies which make them prosper in the market.Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=985407
Major factors contributing to the growth of the global vascular stents market include technological advancements, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population. However, the presence of alternative treatments for cardiovascular diseases, stringent regulations for product approvals, and numerous cases of product failure and recalls are the major factors that are expected to restrain the growth of this market during the forecast period of 2016 to 2021.
Various companies are focusing on R&D activities to improve their vascular stent offerings. Companies like Abbott Laboratories and Boston Scientific are focusing on the development of biodegradable stents to offer effective products that overcome the complications caused by thrombosis [resulting from long-term device implantation]. For instance, in May 2014, Boston Scientific (U.S.) launched the Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Japan.
Currently, the vascular stents market is witnessing a new phase of technology development with the launch of fully dissolving stents. In July 2016, Abbott Laboratories (U.S.) received the U.S. FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the fully dissolving stent approved for the treatment of CAD. Furthermore, a number of bioabsorbable stents for treating PAD are in clinical trials. Some of these products include 480 Biomedical’s Stanza bioresorbable self-expanding scaffold [which is currently under SPIRIT trial and will be used to treat PAD for superficial femoral artery (SFA)] and the Esprit bioresorbable vascular scaffold (BVS) from Abbott Vascular [will be used in the treatment of PAD for SFA and iliac lesions].
The Asian market is estimated to register the highest growth during the forecast period. The high-growth in this regional segment can be attributed to the presence of a large population base, growing prevalence of vascular diseases, rising adoption of advanced technologies, and low manufacturing costs for medical devices in emerging Asian countries.
Research Coverage:
This market is categorized on the basis of product, type, mode of delivery, material, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of top players in the vascular stents market. The report analyzes this market by product, type, mode of delivery, material, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the vascular stents market
Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the vascular stents market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for vascular stents across regions
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular stents market.
Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=985407
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Industry Insights
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Vascular Stents: Market Overview
4.2 Vascular Stent Market, By Product (2016–2021)
4.3 Vascular Stent Market, By Mode of Delivery (2016 Vs. 2021)
4.4 Market, By Material (2016 Vs. 2021)
4.5 Peripheral Market, By Type (2016)
4.6 Market, By End User (2016 Vs. 2021)
4.7 Geographic Snapshot: Vascular Stent Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Innovations In Stenting Technologies
5.2.1.2 Rising Incidence of Vascular Diseases and Subsequent GRoWth In the Number
5.2.1.3 Increasing Preference for Minimally Invasive Procedures
5.2.1.4 Rapid GRoWth In the Geriatric Population
5.2.2 Restraints
5.2.2.1 Availability of Alternative Treatment Methods for Vascular Diseases
5.2.2.2 Product Failures and Recalls
5.2.3 Opportunities
5.2.3.1 Development of Bioresorbable Stents
5.2.3.2 Emerging Markets
5.2.4 Challenges
5.2.4.1 Complications Associated With Stent Implantation
5.2.4.2 Declining Costs of Stents
5.3 Regulatory Landscape
5.4 Product Pipeline
6 Vascular Stent Market, By Type
6.1 Introduction
6.2 Drug-Eluting Stents
6.3 Bare-Metal Stents
6.4 Bioabsorbable Stents
7 Vascular Stent Market, By Product
7.1 Introduction
7.2 Coronary Stents
7.3 Peripheral Stents
7.3.1 Carotid Artery Stents
7.3.2 Renal Artery Stents
7.3.3 Femoral Artery Stents
7.3.4 Iliac Artery Stents
7.3.5 Other Peripheral Stents
7.4 Evar Stent Grafts
7.4.1 Abdominal Aortic Aneurysm Stents
7.4.2 Thoracic Aortic Aneurysm Stents
8 Vascular Stent Market, By Mode of Delivery
8.1 Introduction
8.2 Balloon-Expandable Stents
8.3 Self-Expanding Stents
9 Vascular Stent Market, By Material
9.1 Introduction
9.2 Metallic Stents
9.2.1 Cobalt Chromium
9.2.2 Platinum Chromium
9.2.3 Nickel Titanium
9.2.4 Stainless Steel
9.3 Other Stents
10 Vascular Stent Market, By End User
10.1 Introduction
10.2 Hospitals and Cardiac Centers
10.3 Ambulatory Surgical Centers
11 Vascular Stent Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Rest of Europe
11.4 Asia
11.5 Rest of the World
12 Competitive Landscape
12.1 Overview
12.2 Market Ranking Analysis, Vascular Stent Market
12.3 Vendor Dive Overview
12.3.1 Vanguards
12.3.2 Dynamic Players
12.3.3 Innovators
12.3.4 Emerging Players
12.4 Business Strategy (for All 25 Players)
12.5 Product offerings (for All 25 Players)
*Top 25 Companies Analyzed for This Study Are - Abbott Laboratories (U.S.), B. Braun Melsungen Ag (Germany), Biosensors International (Singapore), Biotronik Se & Co. Kg (Germany), Boston Scientific Corporation (U.S.), Braile Biomédica (Brazil), C. R. Bard (U.S.), Cook Medical(U.S.), Cordis Corporation (U.S.), Endologix, Inc. (U.S.), Grinm Advanced Materials Co., Ltd (China), Insitu Technologies (U.S.), Jotech Gmbh(Germany), Lifetech Scientific Inc. (China), Lombard Medical (U.K.), Medtronic Plc (Ireland), Meril Life Sciences (India), Microport Scientifc Corporation (China), Orbusneich (Hong Kong), S&G Biotech (South Korea), Stentys S.A. (France), Terumo Corporation (Japan), Translumina Gmbh (Germany), Vascular Concepts (India), and W. L. Gore & Associates (U.S
13 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm Vie
13.1 Introduction
13.2 Medtronic Plc
13.3 Abbott Laboratories
13.4 Boston Scientific Corporation
13.5 Biotronik Se & Co. Kg
13.6 B. Braun Melsungen Ag
13.7 Terumo Corporation
13.8 Microport Scientific Corporation
13.9 Meril Life Sciences Pvt. Ltd.
13.10 Vascular Concepts Limited
13.11 C.R. Bard, Inc.
13.12 W.L. Gore and Associates, Inc.
13.13 Endologix, Inc.
13.14 Lombard Medical
13.15 Translumina Gmbh
13.16 Jotec Gmbh
*Details On Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured In Case of Unlisted Compani
14 Appendix
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing Rt: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details
Purchase the Report Directly @ https://www.reportsnreports.com/purchase.aspx?name=985407
Contact Us:
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vascular Stent Market 2021 Research by Type, Product, Material, End User, Growth Rate, CAGR and Top Companies Analysis here
News-ID: 2318335 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…